Markets › India › BOM › TRABI

Transgene Biotek Limited

BOM:TRABIHealthcare

₹2.49+0.00%Delayed 15 minIn session · ≈ AED 0.0963 · Market cap $1.72M

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	64.1%	153.3%	−20.4%	−72.0%	100.0%	−296.7%	—	—
Operating margin	−6,154.6%	−11,982.0%	−10,897.1%	−301.8%	−466.6%	−351.6%	−351.6%	+0.0 pts
Net margin	−6,154.3%	−11,998.4%	−10,907.9%	−279.1%	−259.3%	−782.6%	−782.6%	+0.0 pts
EBITDA margin	−150.8%	−286.7%	−1,592.4%	−184.7%	−130.4%	−257.3%	—	—
Return on equity	−46.9%	−59.9%	−52.9%	9.5%	−6.7%	−19.7%	−19.7%	+0.0 pts
Return on assets	−6.7%	−7.1%	−4.2%	−0.5%	−0.5%	−1.2%	−1.2%	+0.0 pts
Return on capital employed	−7.3%	−7.5%	−4.6%	−0.5%	−0.9%	−0.6%	—	—
Debt / equity	0.5×	0.7×	1.2×	−2.0×	1.4×	2.0×	2.0×	+0.0%
Debt / assets	7.2%	8.2%	9.2%	9.8%	10.1%	11.9%	—	—
Interest coverage	−38.5×	−45.3×	−9.6×	−5.1×	−5.0×	−0.7×	—	—
Current ratio	0.0×	0.1×	0.1×	0.1×	0.1×	0.1×	0.1×	+0.0%
Quick ratio	0.0×	0.1×	0.1×	0.1×	0.1×	0.1×	—	—
Cash ratio	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Inventory turnover	3.0×	−0.5×	2.0×	11.9×	43.4×	24.6×	—	—
Receivables turnover	20.1×	10.3×	6.6×	28.0×	31.0×	25.1×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.